BioCentury
ARTICLE | Company News

Acusphere, Nycomed Group A/S deal

July 12, 2004 7:00 AM UTC

Nycomed licensed from ACUS exclusive European rights to develop and market AI-700, a synthetic porous microparticle polymer ultrasound contrast agent. The territory includes the Commonwealth of Indep...